← Back to Search

Referral to harm reduction services for Opioid Use Disorder (ETHIC Trial)

N/A

Waitlist Available

Led By Mai Pho, PhD

Research Sponsored by University of Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 years

Awards & highlights

ETHIC Trial Summary

This trial will help build programs to refer people who use drugs to harm reduction services, including syringe services, naloxone overdose prevention, and referral for substance use treatment.

Eligible Conditions

Opioid Use Disorder
Hepatitis C
HIV/AIDS
Drug Injection

ETHIC Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Referrals to the harm reduction organization

Secondary outcome measures

Amount of time to travel to the nearest syringe or needle exchange

Number of HCV screenings and referrals

Number of HIV screenings and referrals

+11 more

ETHIC Trial Design

1Treatment groups

Experimental Treatment

Group I: Referral to harm reduction servicesExperimental Treatment1 Intervention

Participants will be taken through the study survey and interview, blood and urine toxicology testing and given a referral to a harm reduction organization.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Referral to harm reduction services

2020

N/A

~310

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH

2,467 Previous Clinical Trials

2,618,814 Total Patients Enrolled

University of WashingtonOTHER

1,739 Previous Clinical Trials

1,847,633 Total Patients Enrolled

New York UniversityOTHER

226 Previous Clinical Trials

313,946 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people is the research team recruiting for this experimental investigation?

"Affirmative. Clinicaltrials.gov indicates that the trial is actively enrolling patients; first posted on August 14th 2020, and recently updated on October 28th 2022. In total 600 individuals are expected to participate in this research between 2 medical sites."

Answered by AI

Are new applicants welcome to join the experiment?

"Affirmative. According to clinicaltrials.gov, this trial is currently recruiting subjects and was initially advertised on August 14th 2020; the data was last updated on October 28th 2022. 600 patients must be enrolled from two distinct medical facilities."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC)

2020. "Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04427202.